$0.5700
0.036.52%
At close: -
$0.5800
0.011.75%
After Hours: 6:32 PM EDT
Bolt Biotherapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Bolt Biotherapeutics using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-12 | $-0.40 | $-0.35 | -14.3 % |
Q2 | 2024-08-13 | $-0.56 | $-0.48 | -16.7 % |
Q1 | 2024-05-14 | $-0.28 | $-0.51 | 45.1 % |
Q4 | 2024-03-21 | $-0.47 | $-0.48 | 2.08 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-12 | $1.14M | $1.26M | -9.44 % |
Q2 | 2024-08-13 | $1.27M | $891.50K | 43.0 % |
Q1 | 2024-05-14 | $5.27M | $2.06M | 156.0 % |
Q4 | 2024-03-21 | $2.09M | $1.71M | 22.2 % |
Bolt Biotherapeutics (BOLT) is scheduled to report earnings on March 20, 2025. The last reported earnings were for reported on November 12, 2024 for Q3.
The Actual EPS was $-0.40, which missed the estimate of $-0.35.
The Actual Revenue was $1.1M, which missed the estimate of $1.3M.
Browse earnings estimates, EPS, and revenue on all stocks.